| 영문 | german measles | 한글 | 풍진 |
|---|---|---|---|
| 설명 | Rubella, 또는 '3일 홍역'이라고 불리는 이 병은 풍진바이러스의 감염에 의한 병으로 주로 소아기에 흔한 질병이다. 전염성이 아주 강하고 성인기에 걸렸을 경우에는 일반적으로 소아기때보다 증상이 심하다. 풍진바이러스인 Togaviridae family의 Rubivirus라는 종에 의하여 생긴다. 전염방식은 기침이나 재채기 또는 말할 때 튀어 나오는 침에 섞여 있는 작은 바이러스 입자로 전파된다. 임신부가 풍진에 감염되면 태반을 통하여 태아에 전염된다. 잠복기는 14~21일(대개 17일) 증상은 그 특징에 따라서 전구기와 발진기로 나눈다. |
||
| 영문 | rubeola, measles | 한글 | 홍역 |
|---|---|---|---|
| 설명 | 주로 호흡기계와 그물내피계를 침범하는 고도의 전염성이 있는 바이러스 감염. 전구기 또는 발진초기의 환자에서 유래된 작은 물방울중의 바이러스를 흡입한 지, 약 8일 후에 3~5일간의 전구증이 시작된다. 코감기, 목림프절염, 코풀릭반점(Koplik spot(입안 뺨쪽 구강점막의 특징적인 병터. 이것을 보면 홍역으로 진단가능함), 눈꺼풀결막염, 근육통, 쇄약, 꾸준히 상승하는 열과 심한 기침이 피부 발진에 선행한다. 피부에는 붉은 구진이 귀뒤나 얼굴에 먼저 나타나고 급속히 몸통과 사지에 퍼진다. 구진은 이산되어 있으나 점차 더욱 융합된다. 환부는 편평하게 되고 갈색으로 변하며 제 6일경에 비늘처럼 떨어진다. 이 시기에 체온이 정상으로 돌아온다. 세균성폐렴, 중이염, 뇌막염을 합병하는 수가 있다. 사망률은 홍역 자체의 심한 정도, 합병증 등에 따라 다르다. |
||
| MMR | 1) Measles, Mumps, Rubella; 홍역, 멈프스, 풍진 2) Mass Miniature Radiography... |
|---|---|
| DPTPM | diphtheria-pertussis-tetanus-poliomyelitis-measles [vaccine] |
| HARD | hydrocephalus-agyria-retinal dysplasia [syndrome] |
| HARD | +/- E hydrocephalus-agyria-retinal dysplasia plus or minus encephalocele [syndrome] |
| HE | half-scan with extrapolation; hard exudate; hektoen enteric [agar]; hemagglutinating encephalomyelit... |
| MMR | MEASLES: mumps-rubella |
|---|---|
| MV | Measles virus |
| MMR | Measles, mumps and rubella |
| MMR | Measles-Mumps-Rubella vaccine |
| atypical measles | Sometimes severe, unusual clinical manifestation of natural measles virus infection in persons with waning vaccination immunity, particularly in those who had received formaldehyde-inactivated vaccine; an accelerated allergic reaction apparently resulting from an anamnestic antibody response, characterised by high fever, absence of Koplik's spots, a shortened prodromal period, atypical rash, and pneumonia. (05 Mar 2000) |
|---|---|
| black measles | An acute tick-borne illness caused by the bacteria Rickettsia rickettsii. The disease is characterised by sudden onset of headache, chills and fever which can persist for 2-3 weeks. A characteristic rash appears on the extremities and trunk about the 4th day of illness. (27 Sep 1997) |
| vaccination, german measles | See Vaccination, MMR. (12 Dec 1998) |
| vaccination, measles | See Vaccination, MMR. Vaccination, mmr: the standard vaccine given to prevent measles, mumps and rubella (german measles). The mmr vaccine is now given in two dosages. The first should be given at12-15 months of age. The second vaccination hould be given at 4-6 years (or, alternatively, 11-12 years) of age. most colleges require proof of a second measles or mmr vaccination prior to entrance. Most children should receive mmr vaccinations. Exceptions may include children born with an inability to fight off infection, some children with cancer, on treatment with radiation or drugs for cancer, on long term steroids (cortisone). People with severe allergic reactions to eggs or the drug neomycin should probably avoid the mmr vaccine. Pregnant women should wait until after delivery before being immunised with mmr. People with HIV or aids should normally receive mmr vaccine. Measles, mumps, and rubella vaccines may be administered as individual shots, if necessary, or as a measles-rubella combination. (12 Dec 1998) |
| palate, hard | The bony part of the roof of the mouth. The hard palate is just in front of the soft palate. (12 Dec 1998) |
| german measles | Rubella is another term for German measles, an acute viral illness that starts as an upper respiratory infection and evolves into a generalised rash. Immunisation is advisable (MMR vaccine). Testing for Rubella antibody titres is performed routinely in pregnant females as a check for German measles immunity. (27 Sep 1997) |
| german measles immunization | The standard MMR vaccine is given to prevent measles, mumps and rubella (German measles). The MMR vaccine is now given in two dosages. The first should be given at12-15 months of age. The second vaccination should be given at 4-6 years (or, alternatively, 11-12 years) of age. most colleges require proof of a second measles or MMR vaccination prior to entrance. Most children should receive MMR vaccinations. Exceptions may include children born with an inability to fight off infection, some children with cancer, on treatment with radiation or drugs for cancer, on long term steroids (cortisone). People with severe allergic reactions to eggs or the drug neomycin should probably avoid the MMR vaccine. Pregnant women should wait until after delivery before being immunised with MMR. People with HIV or AIDS should normally receive MMR vaccine. Measles, mumps, and rubella vaccines may be administered as individual shots, if necessary, or as a measles-rubella combination. (12 Dec 1998) |
| German measles virus | The type (and only) species of rubivirus causing acute infection in humans, primarily children and young adults. Humans are the only natural host. A live, attenuated vaccine is available for prophylaxis. (12 Dec 1998) |
| measles | <virology> An acute infectious disease caused by the measles virus, a Morbillivirus in the paramyxovirus family. Early symptoms include a low-grade fever, dry cough, pinkeye and cold symptoms. Later symptoms include tiny, white spots lining the inside of the cheeks (Koplik spots) and a red rash which starts on the face and spreads. Synonym: rubeola. (27 Sep 1997) |
| measles convalescent serum | Obtained from the blood of a healthy person who has survived an attack of measles. Synonym: measles convalescent serum. (05 Mar 2000) |
| measles immune globulin | A sterile solution of globulin's derived from the blood plasma of normal adult human donors; it is prepared from immune serum globulin that complies with the measles antibody reference standard; a passive immunizing agent. Synonym: measles immunoglobulin. (05 Mar 2000) |
| measles immunization | The standard MMR vaccine is given to prevent measles, mumps and rubella (german measles). The mmr vaccine is now given in two dosages. The first should be given at12-15 months of age. The second vaccination should be given at 4-6 years (or, alternatively, 11-12 years) of age. most colleges require proof of a second measles or mmr vaccination prior to entrance. Most children should receive mmr vaccinations. Exceptions may include children born with an inability to fight off infection, some children with cancer, on treatment with radiation or drugs for cancer, on long term steroids (cortisone). People with severe allergic reactions to eggs or the drug neomycin should probably avoid the mmr vaccine. Pregnant women should wait until after delivery before being immunised with mmr. People with HIV or aids should normally receive mmr vaccine. Measles, mumps, and rubella vaccines may be administered as individual shots, if necessary, or as a measles-rubella combination. (12 Dec 1998) |
| measles immunoglobulin | measles immune globulin (human) |
| measles, mumps and rubella vaccine | A combination of live attenuated measles, mumps, and rubella viruses in an aqueous suspension; used for immunization against the respective diseases. (05 Mar 2000) |
| measles vaccine | A live attenuated virus vaccine of chick embryo origin, used for routine immunization of children and for immunization of adolescents and adults who have not had measles or been immunised with live measles vaccine and have no serum antibodies against measles. Children are usually immunised with measles-mumps-rubella combination vaccine. (12 Dec 1998) |
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|